Acorda Therapeutics Inc (ACORQ) Return on Assets ROA from the first quarter of 2024 to first quarter of 2023 and for the year 2024, Average High and Low, Fundamental Ratios from Mar 31 2024 to Mar 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Acorda Therapeutics Inc   (ACORQ)


Acorda Therapeutics Inc 's ROA from the first quarter of 2024 to the first quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Acorda Therapeutics Inc 's ROA in the first quarter of 2024?
Acorda Therapeutics Inc recorded a cumulative net loss of $-263 million during 12 months ending in the first quarter of 2024, resulting in a negative return on assets (ROA) of -115.01%.

However, within the Healthcare sector 889 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2024 quarter, so far to 4760, from total ROA ranking in the fourth quarter of 2023 at 5149.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Total Assets Change -78.24 % -73.82 % -6.86 % -10.24 % -11.62 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -263 -253 -16 -21 -58
Return On Assets (TTM) -115.01 % -83.62 % -4.25 % -5.47 % -14.83 %
ACORQ's Total Ranking # 4760 # 5149 # 3238 # 3406 # 3895
Total Assets (TTM) in million 82 104 366 365 375
Seq. Total Assets Change -21.23 % -71.73 % 0.45 % -2.71 % -5.24 %
Seq. Net Income Change - - - - -

ACORQ's 5 Years Annual ROA >> Back to ACORQ Management Effectiveness >> Compare ACORQ ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 136
Sector # 890
Overall # 4687

Return On Assets Statistics
High Average Low
24.98 %
-12.39 %
-114.39 %
(Sep 30 2013)   (Mar 31 2024)





Financial Statements
Acorda Therapeutics Inc 's Assets $ 82 million ACORQ's Balance sheet
Acorda Therapeutics Inc 's Income $ -27 million Quarterly ACORQ's Income Statement
ACORQ's Income by Division See ACORQ's Income by Division



Annual Return On Assets (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019
Y / Y Total Assets Change -73.82 % -13.15 % -28.01 % -20.89 % -38.47 %
Total Assets in million 104 396 455 633 800
Y / Y Net Income Change - - - - -
Net Income in million -253 -66 -104 -100 -273
Annual Return On Assets -244.15 % -16.66 % -22.82 % -15.74 % -34.13 %

ACORQ's 5 Years Annual ROA >> Back to ACORQ Management Effectiveness >> Compare ACORQ ROA to its Competitors



More Return On Assets Ratios
ACORQ's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ACORQ's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ACORQ's Competitors
Subscribers only: Roa for Acorda Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for ACORQ's Customers

You may also want to know
ACORQ's Roi ACORQ's Inventory Turnover Ratio ACORQ's Growth Rates ACORQ's Dividend Comparisons
ACORQ's Profitability Ratios ACORQ's Asset Turnover Ratio ACORQ's Dividend Growth
ACORQ's Roe ACORQ's Valuation Ratios ACORQ's Financial Strength Ratios ACORQ's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2024, within Healthcare Sector ROA

Date modified: 2026-08-29T17:28:08+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.